Endometrial Papillary Serous Carcinoma
4 clinical trials · Condition
◉ Watch Endometrial Papillary Serous Carcinoma
| Record | Firm | Date |
|---|---|---|
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors (NCT01198184) | National Cancer Institute (NCI) | 2010-08-01 |
| Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer (NCT00416455) | National Cancer Institute (NCI) | 2007-09-01 |
| Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer (NCT00025467) | National Cancer Institute (NCI) | 2001-09-01 |
Track Endometrial Papillary Serous Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.